What are the UK Retail 5 Leading Brands unit sales in ... - IMS Health
What are the UK Retail 5 Leading Brands unit sales in ... - IMS Health
What are the UK Retail 5 Leading Brands unit sales in ... - IMS Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>What</strong> <strong>are</strong> <strong>the</strong> quarterly <strong>sales</strong> <strong>in</strong> EU 5 Major Markets?<br />
Therapy <strong>are</strong>a <strong>sales</strong> 2008-2009 - R3A B2 Agonists<br />
Therapy Area Sales (USD MNF 000’s)<br />
300,000<br />
250,000<br />
200,000<br />
150,000<br />
100,000<br />
50,000<br />
0<br />
USD/MNF<br />
2008<br />
<strong>UK</strong> 269,108<br />
Germany 190,706<br />
France 186,553<br />
Spa<strong>in</strong> 96,141<br />
Italy 85,653<br />
<strong>UK</strong> Germany France Spa<strong>in</strong> Italy<br />
1 Ask <strong>IMS</strong> Sample deliverable. Contact <strong>IMS</strong> at net<strong>in</strong>fo@uk.imshealth.com<br />
Therapy Area Sales (USD MNF 000’s)<br />
250,000<br />
200,000<br />
150,000<br />
100,000<br />
50,000<br />
0<br />
USD/MNF<br />
2009<br />
<strong>UK</strong> 219,465<br />
Germany 187,091<br />
France 174,670<br />
Spa<strong>in</strong> 74,874<br />
Italy 73,293<br />
<strong>UK</strong> Germany France Spa<strong>in</strong> Italy
<strong>What</strong> <strong>are</strong> <strong>the</strong> total <strong>sales</strong> for a specific product?<br />
<strong>UK</strong> <strong>Retail</strong> R3A Brand Sales<br />
Serevent Quarterly Revenues & Growth 2007-2009<br />
USD Sales Revenue (000's)<br />
30,000<br />
25,000<br />
20,000<br />
15,000<br />
10,000<br />
5,000<br />
0<br />
USD/MNF<br />
QTR/3/08<br />
2 Ask <strong>IMS</strong> Sample deliverable. Contact <strong>IMS</strong> at net<strong>in</strong>fo@uk.imshealth.com<br />
Sales Revenue (USD 000's) % Previous Period Growth<br />
USD/MNF<br />
QTR/6/08<br />
USD/MNF<br />
QTR/9/08<br />
USD/MNF<br />
QTR/12/08<br />
USD/MNF<br />
QTR/3/09<br />
USD/MNF<br />
QTR/6/09<br />
USD/MNF<br />
QTR/9/09<br />
USD/MNF<br />
QTR/12/09<br />
Sales Revenue (USD 000's) 28,245 28,088 26,326 22,716 18,126 20,256 21,138 22,051<br />
% Previous Period Growth -9.2 -10.2 -15.7 -29.8 -35.8 -27.9 -19.7 -2.9<br />
0<br />
-5<br />
-10<br />
-15<br />
-20<br />
-25<br />
-30<br />
-35<br />
-40<br />
% Previous Period Growth
<strong>What</strong> <strong>are</strong> <strong>the</strong> channel <strong>sales</strong> <strong>in</strong> a specific market?<br />
Italy Channel Sales – Respiratory Market<br />
B2 Agonist Quarterly Sales Track<strong>in</strong>g 2007-2009<br />
Sales Revenue <strong>in</strong> USD 000's<br />
30,000<br />
25,000<br />
20,000<br />
15,000<br />
10,000<br />
5,000<br />
0<br />
USD/MN<br />
F<br />
QTR/3/<br />
USD/MN<br />
F<br />
QTR/6/<br />
USD/MN<br />
F<br />
QTR/9/<br />
USD/MN<br />
F<br />
QTR/12<br />
USD/MN<br />
F<br />
QTR/3/<br />
ITALY HOSPITAL 635 558 464 611 710 626 490 545 604 542 476 637<br />
ITALY RETAIL 22,419 22,554 18,900 22,401 23,434 22,686 18,879 18,284 18,150 17,835 15,777 19,272<br />
3 Ask <strong>IMS</strong> Sample deliverable. Contact <strong>IMS</strong> at net<strong>in</strong>fo@uk.imshealth.com<br />
USD/MN<br />
F<br />
QTR/6/<br />
USD/MN<br />
F<br />
QTR/9/<br />
USD/MN<br />
F<br />
QTR/12<br />
USD/MN<br />
F<br />
QTR/3/<br />
USD/MN<br />
F<br />
QTR/6/<br />
ITALY RETAIL ITALY HOSPITAL<br />
USD/MN<br />
F<br />
QTR/9/<br />
USD/MN<br />
F<br />
QTR/12
<strong>What</strong> <strong>are</strong> <strong>the</strong> <strong>sales</strong> and growth <strong>in</strong> a channel? Sales of<br />
M5B top 5 products <strong>in</strong> Italy market channels<br />
Sales Revenue <strong>in</strong> USD (000's)<br />
70,000<br />
60,000<br />
50,000<br />
40,000<br />
30,000<br />
20,000<br />
10,000<br />
0<br />
EUR/MNF<br />
QTR/9/07<br />
EUR/MNF<br />
QTR/12/0<br />
7<br />
EUR/MNF<br />
QTR/3/08<br />
EUR/MNF<br />
QTR/6/08<br />
ITALY HOSPITAL 37,870 40,993 45,479 47,784 47,630 50,431 58,493 61,214<br />
ITALY RETAIL 1,638 1,700 1,677 1,708 1,645 1,681 1,713 1,802<br />
ITALY DPC 546 572 667 712 645 656 644 607<br />
4 Ask <strong>IMS</strong> Sample deliverable. Contact <strong>IMS</strong> at net<strong>in</strong>fo@uk.imshealth.com<br />
EUR/MNF<br />
QTR/9/08<br />
EUR/MNF<br />
QTR/12/0<br />
8<br />
EUR/MNF<br />
QTR/3/09<br />
EUR/MNF<br />
QTR/6/09<br />
ITALY HOSPITAL<br />
ITALY RETAIL<br />
ITALY DPC
<strong>UK</strong> <strong>Retail</strong> – 5 <strong>Lead<strong>in</strong>g</strong> <strong>Brands</strong> <strong>in</strong> Respiratory Market<br />
B2 Agonist Sales 2007-2009<br />
Unit Volumes (000's)<br />
12000<br />
10000<br />
8000<br />
6000<br />
4000<br />
2000<br />
0<br />
UN<br />
QTR/3/07<br />
(Thousands)<br />
UN<br />
QTR/6/07<br />
(Thousands)<br />
UN<br />
QTR/9/07<br />
(Thousands)<br />
UN<br />
QTR/12/07<br />
(Thousands)<br />
UN<br />
QTR/3/08<br />
(Thousands)<br />
UN<br />
QTR/6/08<br />
(Thousands)<br />
5 Ask <strong>IMS</strong> Sample deliverable. Contact <strong>IMS</strong> at net<strong>in</strong>fo@uk.imshealth.com<br />
UN<br />
QTR/9/08<br />
(Thousands)<br />
UN<br />
QTR/12/08<br />
(Thousands)<br />
UN<br />
QTR/3/09<br />
(Thousands)<br />
UN<br />
QTR/6/09<br />
(Thousands)<br />
UN<br />
QTR/9/09<br />
(Thousands)<br />
UN<br />
QTR/12/09<br />
(Thousands)<br />
SEREVENT VENTOLIN SALAMOL BRICANYL SALBUTAMOL L.U.
<strong>What</strong> <strong>are</strong> <strong>the</strong> drugs be<strong>in</strong>g subscribed for a specific<br />
<strong>in</strong>dication? Germany <strong>Retail</strong> RA Prescrib<strong>in</strong>g for top 5<br />
products (Script volumes)<br />
Rx Volumes (000's)<br />
40<br />
35<br />
30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
RX<br />
QTR/3/0<br />
7<br />
RX<br />
QTR/6/0<br />
7<br />
RX<br />
QTR/9/0<br />
7<br />
RX<br />
QTR/12/<br />
07<br />
M.T.X. 34 28 30 29 28 28 32 27<br />
PREDNISOL.M8V(JNA) 22 21 22 23 28 30 29 24<br />
PREDNISOL.GAL.(FER 14 15 19 17 16 18 22 22<br />
METEX 25 23 26 27 32 31 28 22<br />
SOLU DACORTIN 23 28 24 23 24 26 21 22<br />
6 Ask <strong>IMS</strong> Sample deliverable. Contact <strong>IMS</strong> at net<strong>in</strong>fo@uk.imshealth.com<br />
RX<br />
QTR/3/0<br />
8<br />
RX<br />
QTR/6/0<br />
8<br />
RX<br />
QTR/9/0<br />
8<br />
RX<br />
QTR/12/<br />
08<br />
M.T.X.<br />
PREDNISOL.M8V(JNA)<br />
PREDNISOL.GAL.(FER<br />
METEX<br />
SOLU DACORTIN
<strong>What</strong> <strong>are</strong> <strong>the</strong> total market <strong>sales</strong> measured <strong>in</strong><br />
Diagnosis value for Essential Hypertension I10 <strong>in</strong><br />
EU5 retail markets?<br />
Diagnosis Value (DV <strong>in</strong> 000's)<br />
600,000<br />
500,000<br />
400,000<br />
300,000<br />
200,000<br />
100,000<br />
0<br />
USD/MNF/<br />
DVQtr<br />
3/2008<br />
USD/MNF/<br />
DV Qtr<br />
6/2008<br />
USD/MNF/<br />
DV Qtr<br />
9/2008<br />
GERMANY RETAIL 465,805 487,130 496,664 507,448 486,091 507,145 499,480 532,119<br />
FRANC E RETAIL 464,728 483,475 479,571 482,111 475,590 484,953 484,262 480,527<br />
ITALY RETAIL 344,760 339,354 311,093 321,537 335,010 338,771 304,272 313,792<br />
SPAIN RETAIL 229,098 234,542 232,503 224,238 230,315 233,426 230,984 234,018<br />
<strong>UK</strong> RETAIL 197,758 191,699 184,074 178,744 145,319 158,351 162,108 169,209<br />
7 Ask <strong>IMS</strong> Sample deliverable. Contact <strong>IMS</strong> at net<strong>in</strong>fo@uk.imshealth.com<br />
USD/MNF/<br />
DV Qtr<br />
12/2008<br />
USD/MNF/<br />
DV Qtr<br />
3/2009<br />
USD/MNF/<br />
DV Qtr<br />
6/2009<br />
USD/MNF/<br />
DV Qtr<br />
9/2009<br />
USD/MNF/<br />
DV Qtr<br />
12/2009
Change language